Rentokil Initial
RTO | NYSE
$23.96
+$0.64 (+2.74%)
Nov 2, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.91B | 5.44B | 5.38B | 3.71B | 2.95B | 2.79B |
Cost of Revenue | 4.66B | 4.71B | 927M | 704M | 596M | 583M |
Gross Profit | 2.27B | 726M | 4.45B | 3.01B | 728.72M | 2.22B |
Operating Income | 945.89M | 549M | 625M | 317M | 347M | 294M |
Interest Income | 31.03M | 36M | 25M | 5M | 1M | 6M |
Pretax Income | 390.37M | 405M | 493M | 296M | 325M | 230M |
Net Income | 470.44M | 307M | 381M | 232M | 263M | 186M |
Selling & General & Admin | n/a | n/a | 2.87B | 479M | 348.6M | 352M |
Research & Development | n/a | 7M | n/a | 5M | 5M | n/a |
Other Expenses | 1.32B | 170M | 953M | 2.21B | 1.66B | 1.57B |
Operating Expenses | 1.32B | 177M | 3.82B | 2.69B | 2.01B | 1.93B |
Interest Expense | 60.06M | 192M | 189M | 77M | 34M | 40M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.97B | 4.89B | 4.75B | 3.4B | 2.61B | 2.51B |
Income Tax Expense | 100.09M | 98M | 112M | 64M | 61.9M | 44M |
Shares Outstanding (Basic) | 504.8M | 505.6M | 503.2M | 400.4M | 371.62M | 370.64M |
Shares Outstanding (Diluted) | 507M | 505.6M | 505.4M | 402.8M | 373.26M | 372.58M |
EPS (Basic) | 0.95 | 0.60 | 0.75 | 0.60 | 0.70 | 0.50 |
EPS (Diluted) | 0.95 | 0.60 | 0.75 | 0.60 | 0.70 | 0.50 |
EBITDA | 1.51B | 990M | 1.16B | 748M | 580M | 517M |
EBIT | 945.89M | 670M | 682M | 490M | 378M | 303M |
Depreciation & Amortization | 563.53M | 320M | 475M | 258M | 202M | 214M |
Add to Watchlist
Select watchlists to add or remove RTO